BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 7567933)

  • 1. Distribution of cytokeratin 19-positive biliary cells in cirrhotic nodules, hepatic borderline nodules (atypical adenomatous hyperplasia), and small hepatocellular carcinomas.
    Terada T; Hoso M; Nakanuma Y
    Mod Pathol; 1995 May; 8(4):371-9. PubMed ID: 7567933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macroregenerative nodules in a series of adult cirrhotic liver explants: issues of classification and nomenclature.
    Hytiroglou P; Theise ND; Schwartz M; Mor E; Miller C; Thung SN
    Hepatology; 1995 Mar; 21(3):703-8. PubMed ID: 7875667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Precancerous stages of hepatocellular carcinoma].
    Tanikawa K
    Gan To Kagaku Ryoho; 1995 Dec; 22(14):2055-61. PubMed ID: 8607615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.
    Kwon Y; Lee SK; Kim JS; Ro JY; Yu E
    Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent occurrence of hepatocellular carcinoma in cirrhotic livers after surgical resection of atypical adenomatous hyperplasia (borderline hepatocellular lesion): a follow-up study.
    Kaji K; Terada T; Nakanuma Y
    Am J Gastroenterol; 1994 Jun; 89(6):903-8. PubMed ID: 8198103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological and immunohistochemical analysis of adenomatous hyperplasia and hepatocellular carcinoma: cellularity, thickness of cell cord, and Ki-67 proliferative activity.
    Than KW; Okayasu I; Akashi T
    Bull Tokyo Med Dent Univ; 1995 Jun; 42(2):67-81. PubMed ID: 7540960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokeratin patterns of liver carcinomas induced by diethylnitrosamine in monkeys.
    Lapis K; Sarosi I; Bocsi J; Thorgeirsson UP
    Lab Invest; 1995 Jun; 72(6):748-59. PubMed ID: 7540236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor in cirrhotic liver, adenomatous hyperplastic nodule and hepatocellular carcinoma in the human.
    Nagasue N; Yamanoi A; Kohno H; Kimoto T; Chang Y; Taniura H; Uchida M; Nakamura T
    Hepatogastroenterology; 1992 Oct; 39(5):455-60. PubMed ID: 1334038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study.
    Seki S; Sakaguchi H; Kitada T; Tamori A; Takeda T; Kawada N; Habu D; Nakatani K; Nishiguchi S; Shiomi S
    Clin Cancer Res; 2000 Sep; 6(9):3469-73. PubMed ID: 10999730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
    Coston WM; Loera S; Lau SK; Ishizawa S; Jiang Z; Wu CL; Yen Y; Weiss LM; Chu PG
    Am J Surg Pathol; 2008 Mar; 32(3):433-44. PubMed ID: 18300806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential diagnosis of hepatocellular nodular lesions.
    Hytiroglou P; Theise ND
    Semin Diagn Pathol; 1998 Nov; 15(4):285-99. PubMed ID: 9845429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenascin and type IV collagen expression in liver cell dysplasia and in hepatocellular carcinoma.
    Zhao M; Laissue JA; Zimmermann A
    Histol Histopathol; 1996 Apr; 11(2):323-33. PubMed ID: 8861754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules.
    Libbrecht L; Severi T; Cassiman D; Vander Borght S; Pirenne J; Nevens F; Verslype C; van Pelt J; Roskams T
    Am J Surg Pathol; 2006 Nov; 30(11):1405-11. PubMed ID: 17063081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of micronuclei formation and nuclear anomalies in regenerative nodules of human cirrhotic livers and relationship to hepatocellular carcinoma.
    de Almeida TM; Leitão RC; Andrade JD; Beçak W; Carrilho FJ; Sonohara S
    Cancer Genet Cytogenet; 2004 Apr; 150(1):16-21. PubMed ID: 15041218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'.
    Kozaka K; Sasaki M; Fujii T; Harada K; Zen Y; Sato Y; Sawada S; Minato H; Matsui O; Nakanuma Y
    Histopathology; 2007 Sep; 51(3):390-400. PubMed ID: 17553067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic precancerous lesions and small hepatocellular carcinoma.
    Hytiroglou P; Park YN; Krinsky G; Theise ND
    Gastroenterol Clin North Am; 2007 Dec; 36(4):867-87, vii. PubMed ID: 17996795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
    Szczepański W
    Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathological significance of adenomatous hyperplasia of the liver].
    Nakashima O; Kojiro M
    Nihon Rinsho; 1994 Jan; 52(1):75-9. PubMed ID: 8114314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.